Red List:Official warnings and scam reports, with sourcesCheck a link
Check a link
Regulatory warningOfficial actionRegulatory note

Golden CBD Plus (USA)

Anvisa banned sales and promotion of eight Golden CBD Plus products sold without registration

Not yet reviewed by our editors. This entry reports what the cited sources say; it may change as we check it. How we check

This entry is about Brazil — not the country you picked in the header.

According to Brazilian Health Regulatory Agency (Anvisa), Oct 15, 2025 · Read the source · +1 more

Where
Brazil
First reported
Last checked

Summary

Anvisa announced on 16 October 2025 that it had prohibited the sale and promotion in Brazil of eight cannabis products from Golden CBD Plus, described as a US company. The resolution, dated 13 October and published in the official gazette on 15 October, covers every batch.

The agency says the products were being advertised and sold with no Anvisa registration or authorization, and that the manufacturer holds no Anvisa operating authorization to make them. The list includes nano CBD/CBG/CBN and CBD/CBG/CBC formulations named Sleep, Painkiller, Anti-Anxiety, Neurogenic and T-Immune, a 200 mg/ml cannabidiol product, and everything sold under the Golden CBD+ Nanotech and Golden CBD Plus brands.

What the source found

  • Resolution RE 4.030 of 13 October 2025 (DOU 15 October)
  • Products: Sleep, Painkiller, Anti-Anxiety, Neurogenic and T-Immune formulations; Canabidiol 200 mg/ml; all Golden CBD+ Nanotech and Golden CBD Plus items, all batches
  • Reason cited: no registration or authorization; manufacturer lacks an operating authorization

Products named

  • CBD/CBG/CBN nano drops
  • cannabidiol 200 mg/ml

Timeline

  1. Anvisa prohibition announced

Sources

  1. Regulator

    Brazilian Health Regulatory Agency (Anvisa) · Oct 15, 2025

    Anvisa proíbe oito produtos de Cannabis sem registro da Golden CBD Plus
  2. Regulator

    Diário Oficial da União · Oct 15, 2025

    Resolução-RE 4.030/2025

Wording on this page follows the sources. Found an error? See the corrections process in our editorial policy.

Status notes

[dataset] Anvisa news releases on fiscalização (resolutions RE), retrieved 2026-09-30. Anvisa's measure also applies to anyone who advertises or sells the named products in Brazil.

Comments

No comments yet.

Comments are read by a moderator before they’re published.

The full Red List
Regulatory warningOfficial action

Vitanabis Intermediação e Serviços Ltda.

Vitanabis

Anvisa prohibited all cannabis derivatives sold by Vitanabis and advertised online

Brazil · Aug 3, 2026
Regulatory warningOfficial action

Leve CDB

Leve CDB

Anvisa prohibited the Leve CDB Full Spectrum cannabis oil 6,000 mg sold through its official website

Brazil · Dec 9, 2025
Regulatory warningOfficial action

Cannabis Oil

cpag.supersalelinks[.]org/ujih/

Listed by Czech medicines regulator SÚKL as a website illegally offering an unapproved 'Cannabis Oil' preparation

Czechia · Oct 31, 2025
Report a seller

Tell us what happened

Every report is read by a person. You don’t need to prove anything, and we never publish your name.

What happens next
  • A moderator reads your report and checks the link against the Red List and our seller records.
  • We look for an authoritative source — a regulator, court, police or consumer-protection finding.
  • When a source confirms it, your report is linked to a Red List entry. Your name and contact details stay private.
Report a seller

Self-check · 2 minutes · private

Is cannabis becoming a problem for you?

Eight questions from CUDIT-R, a screening test used by clinicians. Your answers never leave this page.